Pfizer Inc. buy Scotiabank
Start price
14.11.25
/
50%
€21.90
Target price
14.11.26
-
Performance (%)
-0.62%
Price
22:26
€21.77
Summary
This prediction is currently active. Since the start of the prediction for Pfizer Inc. the price has only changed by -0.62%. This prediction currently runs until 14.11.26. The prediction end date can be changed by Scotiabank at any time. Scotiabank has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Pfizer Inc. | 1.036% | 1.036% |
| iShares Core DAX® | 2.032% | 3.499% |
| iShares Nasdaq 100 | -0.145% | -1.849% |
| iShares Nikkei 225® | 4.507% | 1.976% |
| iShares S&P 500 | 0.331% | -0.103% |
Comments by Scotiabank for this prediction
In the thread Pfizer Inc. diskutieren
Pfizer (NYSE:PFE) was upgraded by analysts at Scotiabank to a "strong-buy" rating.
Ratings data for PFE provided by MarketBeat